Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Trends in Pharmacological Sciences|August 14, 2003
Animal models of stroke: do they have value for discovering neuroprotective agents?A Richard Green, Tomas Odergren, Tim Ashwood
Pharmacology & Therapeutics|December 4, 2003
Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059A Richard Green, Tim Ashwood, Tomas Odergren, et al.
European Journal of Clinical Pharmacology|September 21, 2002
Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute strokeStig Strid, Olof Borgå, Charlotte Edenius, et al.
Clinical Pharmacokinetics|July 21, 2005
Population pharmacokinetic modelling and estimation of dosing strategy for NXY-059, a nitrone being developed for strokeSiv Jönsson, Yi-Fang Cheng, Charlotte Edenius, et al.
European Journal of Clinical Pharmacology|May 8, 2003
Pharmacokinetics and sedative effects in healthy subjects and subjects with impaired liver function after continuous infusion of clomethiazoleCarina Centerholt, Marianne Ekblom, Tomas Odergren, et al.
British Journal of Clinical Pharmacology|August 5, 2003
Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patientsPer-Henrik Zingmark, Marianne Ekblom, Tomas Odergren, et al.
Molecular and Cellular Neurosciences|June 6, 2021
Elevated soluble amyloid beta protofibrils in Down syndrome and Alzheimer's diseaseMalin Johannesson, Charlotte Sahlin, Linda Söderberg, et al.
Critical Care Medicine|January 7, 2004
Early impairment in consciousness predicts mortality after hemispheric ischemic strokeBrett L Cucchiara, Scott E Kasner, David A Wolk, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 6, 2025
Exidavnemab binds to aggregated α-synuclein in human brains affected by α-synucleinopathiesOlof Zachrisson, Malin Johannesson, Linda Söderberg, et al.
Neuroscience Letters|April 13, 2021
Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brainsEleni Gkanatsiou, Charlotte Sahlin, Erik Portelius, et al.
Pageof 2